| Name | Title | Contact Details |
|---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
SleepImage Ring The SleepImage Rings stream data to the SleepImage Mobile App for upload, offering the highest level of comfort and convenience. SleepImage Mobile App The SleepImage Mobile App collects sleep data and automatically uploads it in the mo...
Squip is a Lebanon, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Avantec Software is a Redmond, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Progressive Home Health Care is a Wichita, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.